Working for customers it could not have served a year ago: the company's deliverable capability just stepped up a class
The model's full reasoning — Q1 2023 call → NOWe need to determine if management conveys a capability step-change with all three elements: before/after, paying work, and early stage. Let's analyze the transcript. Management discusses several businesses: manufacturing facility, Nebula Genomics, esophageal cancer test, Linebacker, clinical lab, COVID testing. Key points: - Manufacturing facility: "at capacity for which we have enormous demand" and "revenues are running up almost a 100% year over year" and "demand for at least $25 million of revenues next year in 2024" and "we're just constrained by how quickly we can build out the additional capacity, which is going to take this year to do so." This suggests they are expanding capacity, but the capability to produce more is not yet in place. They are currently at capacity, so they can produce what they can, but the step-up is about building more capacity. The before/after? They are at capacity now, but they are building additional capacity. The paying work? They have demand and revenues running up, but the new capability (additional capacity) is not yet operational. So this is about future expansion, not a step-change already proven. - Nebula Genomics: "We are waiting for the validations, which will take another couple of months and then we will start to build out those businesses in the second half of this year with our whole genome sequencing business. Right now, we process our specimens abroad. We cannot aggressively build a B2B business until we are processing these specimens in-house." So the capability to process in-house is not yet available; they are waiting for validations. So no paying work exercising that new capability yet. They are currently processing abroad, so the new capability is not proven. - Esophageal cancer test: "commercialized early next year" and "we are just looking to do more studies" and "we are looking to commercialize this next year." So not yet commercialized, no paying work. - Linebacker: still in development, studies, no paying work. - Clinical lab: "we are waiting for the validations to be complete to actually start that testing. So that business will start to ramp up later this year." So not yet. - COVID testing: declining, not a new capability. Thus, there is no capability that is already proven by paying work that was not possible a year ago. The company is still building, validating, and waiting for approvals.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| LINC | Lincoln Educational Services Corporation | Q1 2024 | 2024-05-06 | B+ |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| SANG | Sangoma Technologies Corporation | Q2 2024 | 2024-02-08 | D |
| OPAD | Offerpad Solutions Inc. | Q3 2023 | 2023-11-01 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| TSSI | TSS, Inc. | Q4 2022 | 2023-04-03 | D |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| M | Macy's, Inc. | Q4 2022 | 2023-03-02 | D |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| CNXC | Concentrix Corporation | Q1 2022 | 2022-03-30 | B |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| NGVT | Ingevity Corporation | Q4 2021 | 2022-02-25 | B |
| VNDA | Vanda Pharmaceuticals Inc. | Q4 2021 | 2022-02-23 | F |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| EXP | Eagle Materials Inc. | Q3 2022 | 2022-01-27 | B |
| LC | LendingClub Corporation | Q4 2021 | 2022-01-26 | A |
| SXC | SunCoke Energy, Inc. | Q3 2021 | 2021-11-01 | A |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| CUBI | Customers Bancorp, Inc. | Q3 2018 | 2018-10-26 | C+ |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| TOUR | Tuniu Corporation | Q4 2017 | 2018-03-14 | D |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| AEHR | Aehr Test Systems | Q2 2017 | 2017-01-05 | F |
| NTCT | NetScout Systems, Inc. | Q2 2017 | 2016-10-27 | D |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
TGLS · Q2 2023 → YESThe question is about whether management conveys a new capability that they can now do something they couldn't do a year ago, that customers are paying for now, and it's still early. YES Management explicitly contrasts the new capability against the prior limitation: extra capacity now enables them to sell stand-alone architectural glass and aluminum framing products that were previously allocated to window production due to capacity constraints. This is a clear before/after step-change in the class of work they can accept and perform. Real customers are already paying for this new output: the transcript states they have a little bit more installation in stand-alone product sales the rest of the year, and they are now very well positioned to increasingly service large homebuilders’ customers as well as demand for the stand-alone aluminum and glass products, with the absorption of new capacity and ability to offer a wider range of solutions to customers described as positive overall.
TACT · Q4 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES The transcript shows management describing a clear before/after step-change in casino and gaming printers: they could produce printers before, but now they have added a third line in Q3 and begun manufacturing on a fourth line in Q4, enabling them to meet demand and take market share that the prior competitor could not supply 12 months ago.
ZVIA · Q1 2022 → YESThe question is: Does management convey that the company CAN NOW ACTUALLY DO SOMETHING that it COULD NOT DO ROUGHLY A YEAR AGO, and that REAL CUSTOMERS ARE ALREADY PAYING FOR THAT NEW CAPABILITY NOW, ...YES Management describes the launch of single-serve 12-ounce cans as a first-time capability: “we began selling Zevia’s soda in single cans for the first time in a 12-ounce sleek format,” now “available cold in several grocery retailers” with “some of which is shipping now.